Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Liposarcoma, Myxoid × Pioglitazone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 8 Insulin Resistance 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Diabetes Mellitus, Type 2 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Urinary Bladder Neoplasms 2 Metabolic Syndrome 2 Leukoplakia, Oral 2 Leukemia, Myeloid, Chronic-Phase 2 Inflammation 2 Diabetes Mellitus 2 Carotid Intimal Medial Thickness 1 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Sleep Apnea, Obstructive 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Pharmacokinetics of MDV3100 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Meningioma 1 Memory Disorders 1 Lung Neoplasms 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Hypogonadism 1 Hyperinsulinism 1

Interventions

Cyclophosphamide 11 fludarabine 6 Trabectedin 4 seclidemstat 2 pembrolizumab 2 Topotecan 2 Radiation Dose Hypofractionation 2 Interferon-gamma 2 selinexor 1 pazopanib 1 palbociclib 1 mirdametinib 1 itacitinib 1 interferon gamma-1b 1 fludarabine phosphate 1 brostallicin 1 baricitinib 1 atezolizumab 1 X-Rays 1 Specimen Handling 1 Sirolimus 1 Radiotherapy 1 Radiation 1 Proton Therapy 1 Pioglitazone 1 Phantoms, Imaging 1 Magnetic Resonance Spectroscopy 1 Leukapheresis 1 Ifosfamide 1 INCB039110 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04794127 2026-02-18

TRABEPIO

Mario Negri Institute for Pharmacological Research

Phase 2 Completed

Liposarcoma, Liposarcoma, Myxoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡